We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > European Commission

News List

European Commission approves Johnson & Johnson’s proposed acquisition of Actelion pharmaceutical-technology
June 14, 2017
The European Commission (EC) has granted approval for the proposed acquisition of Swiss-based pharmaceuticals and biotechnology company Actelion by Johnson & Johnson.
European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Se americanpharmaceuticalreview
February 15, 2017
Eli Lilly and Company and Incyte Corporation announced that the European Commission has granted marketing authorization for Olumiant® (baricitinib) 4 mg and 2 mg film-coated tablets in Europe for the treatment of moderate-to-severe active rheumatoid arthr
European Commission Grants Orphan Drug Designation to Cabiralizumab (FPA008) for Pigmented Villonodu firstwordpharma
January 25, 2017
Five Prime Therapeutics, Inc. (Nasdaq:FPRX) today announced that the European Commission has granted orphan designation for cabiralizumab (FPA008) for the treatment of tenosynovial giant cell tumour.
European Commission Initiative Improves Information for Patients on Biosimilar Medicines firstwordpharma
January 24, 2017
Today, the European Commission published a unique Q&A for patients with reliable information on biosimilar medicines.

Previous page 1 2 3 Next page